Ignite Creation Date:
2025-12-24 @ 5:21 PM
Ignite Modification Date:
2026-02-03 @ 7:41 AM
Study NCT ID:
NCT05263050
Status:
RECRUITING
Last Update Posted:
2025-12-03
First Post:
2022-02-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors
Sponsor:
Fox Chase Cancer Center
Organization: